Skip to main content
Log in

Use of eslicarbazepine reduces healthcare use in paediatric focal seizures

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. The study was funded by Sunovion Pharmaceuticals, Inc.

Reference

  • Mehta D, et al. Healthcare Resource Utilization Pre- and Post-Initiation of Eslicarbazepine Acetate Among Pediatric Patients with Focal Seizure: Evidence from Routine Clinical Practice. ClinicoEconomics and Outcomes Research : 23 Jul 2020. Available from: URL: https://doi.org/10.2147/CEOR.S261960

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Use of eslicarbazepine reduces healthcare use in paediatric focal seizures. PharmacoEcon Outcomes News 859, 34 (2020). https://doi.org/10.1007/s40274-020-7043-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7043-7

Navigation